1. Home
  2. Directory
  3. Mississippi
  4. Jackson
  5. Hospitalist
  6. NPI Profile
  7. Prescriptions 1194353391

BRIANNA ARRINGTON MD
Prescription History 1194353391
Hospitalist in Jackson, MS

NPI Status: Active since April 01, 2020

Contact Information

1225 N STATE ST
JACKSON, MS
ZIP 39202
Phone: (601) 988-5281
Fax: (601) 974-6241

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for BRIANNA ARRINGTON MD, an active Hospitalist specialist practicing in Jackson, MS. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 60 documented patient claims. Among these therapy options, the most frequently utilized medication is Meloxicam, which accounts for 19 claims alone.

Medication Index

A
C
G
M
No matching medications currently found on file.

Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 14
30-Day Fills 42.0
Days Supply 1,260
MS State Average Benchmarks
Peer Average Claims170.0
Peer Average 30-Day Fills375.8
Peer Average Days Supply10,959
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 91.8% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $136.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.78

State Avg Cost Per Claim

$10.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Citalopram Hbr

Generic Formulation: Citalopram HydrobromideSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.0
Days Supply 420
MS State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills98.3
Peer Average Days Supply2,848
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.5% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $33.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.78

State Avg Cost Per Claim

$7.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A furancarbonitrile that is one of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.

Therapeutic Applications

Citalopram is used to treat depression. It may improve your energy level and feelings of well-being. Citalopram is known as a selective serotonin reuptake inhibitor (SSRI). This medication works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 15
30-Day Fills 25.0
Days Supply 750
MS State Average Benchmarks
Peer Average Claims134.0
Peer Average 30-Day Fills203.8
Peer Average Days Supply5,876
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 88.8% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $225.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.02

State Avg Cost Per Claim

$19.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Hospitalist
Provider Metrics Summary
Total Claims 19
30-Day Fills 21.7
Days Supply 644
MS State Average Benchmarks
Peer Average Claims78.0
Peer Average 30-Day Fills135.5
Peer Average Days Supply3,966
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 75.6% less volume than the regional standard for practitioners inside MS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $65.41 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.44

State Avg Cost Per Claim

$6.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like BRIANNA ARRINGTON MD provides transparency into local medical care patterns within Jackson, MS.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Hospitalist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.